Logo image of DLB

DOLBY LABORATORIES INC-CL A (DLB) Stock Fundamental Analysis

USA - NYSE:DLB - US25659T1079 - Common Stock

65.875 USD
-0.44 (-0.67%)
Last: 11/3/2025, 12:54:55 PM
Fundamental Rating

7

DLB gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. DLB gets an excellent profitability rating and is at the same time showing great financial health properties. DLB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

DLB had positive earnings in the past year.
DLB had a positive operating cash flow in the past year.
Each year in the past 5 years DLB has been profitable.
In the past 5 years DLB always reported a positive cash flow from operatings.
DLB Yearly Net Income VS EBIT VS OCF VS FCFDLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.27%, DLB belongs to the top of the industry, outperforming 82.39% of the companies in the same industry.
DLB has a Return On Equity of 10.15%. This is in the better half of the industry: DLB outperforms 77.46% of its industry peers.
DLB's Return On Invested Capital of 8.51% is amongst the best of the industry. DLB outperforms 81.34% of its industry peers.
DLB had an Average Return On Invested Capital over the past 3 years of 8.02%. This is below the industry average of 11.84%.
The last Return On Invested Capital (8.51%) for DLB is above the 3 year average (8.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.27%
ROE 10.15%
ROIC 8.51%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
DLB Yearly ROA, ROE, ROICDLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of DLB (19.62%) is better than 83.45% of its industry peers.
DLB's Profit Margin has been stable in the last couple of years.
DLB has a Operating Margin of 21.47%. This is amongst the best in the industry. DLB outperforms 88.03% of its industry peers.
DLB's Operating Margin has declined in the last couple of years.
The Gross Margin of DLB (88.52%) is better than 95.42% of its industry peers.
In the last couple of years the Gross Margin of DLB has remained more or less at the same level.
Industry RankSector Rank
OM 21.47%
PM (TTM) 19.62%
GM 88.52%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
DLB Yearly Profit, Operating, Gross MarginsDLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

DLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DLB has less shares outstanding than it did 1 year ago.
DLB has less shares outstanding than it did 5 years ago.
DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DLB Yearly Shares OutstandingDLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DLB Yearly Total Debt VS Total AssetsDLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 8.67 indicates that DLB is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.67, DLB belongs to the top of the industry, outperforming 81.34% of the companies in the same industry.
There is no outstanding debt for DLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.67
ROIC/WACC0.77
WACC11.05%
DLB Yearly LT Debt VS Equity VS FCFDLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

DLB has a Current Ratio of 3.44. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.44, DLB belongs to the top of the industry, outperforming 80.63% of the companies in the same industry.
DLB has a Quick Ratio of 3.36. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.36, DLB belongs to the best of the industry, outperforming 80.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 3.36
DLB Yearly Current Assets VS Current LiabilitesDLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.81% over the past year.
Measured over the past years, DLB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.26% on average per year.
DLB shows a small growth in Revenue. In the last year, the Revenue has grown by 6.94%.
DLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.51% yearly.
EPS 1Y (TTM)11.81%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%9.86%
Revenue 1Y (TTM)6.94%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%9.25%

3.2 Future

DLB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.93% yearly.
The Revenue is expected to grow by 4.78% on average over the next years.
EPS Next Y5.25%
EPS Next 2Y5.99%
EPS Next 3Y6.93%
EPS Next 5YN/A
Revenue Next Year5.43%
Revenue Next 2Y4.92%
Revenue Next 3Y4.78%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLB Yearly Revenue VS EstimatesDLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
DLB Yearly EPS VS EstimatesDLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.19 indicates a correct valuation of DLB.
Based on the Price/Earnings ratio, DLB is valued cheaper than 83.45% of the companies in the same industry.
DLB is valuated rather cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 15.43, DLB is valued correctly.
Based on the Price/Forward Earnings ratio, DLB is valued cheaply inside the industry as 83.45% of the companies are valued more expensively.
DLB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.55, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.19
Fwd PE 15.43
DLB Price Earnings VS Forward Price EarningsDLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DLB is valued cheaper than 85.21% of the companies in the same industry.
DLB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DLB is cheaper than 88.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.41
EV/EBITDA 15.03
DLB Per share dataDLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DLB has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.08
PEG (5Y)1.75
EPS Next 2Y5.99%
EPS Next 3Y6.93%

6

5. Dividend

5.1 Amount

DLB has a Yearly Dividend Yield of 2.01%. Purely for dividend investing, there may be better candidates out there.
DLB's Dividend Yield is rather good when compared to the industry average which is at 36.27. DLB pays more dividend than 95.07% of the companies in the same industry.
DLB's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

The dividend of DLB is nicely growing with an annual growth rate of 9.47%!
DLB has been paying a dividend for at least 10 years, so it has a reliable track record.
DLB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)9.47%
Div Incr Years10
Div Non Decr Years10
DLB Yearly Dividends per shareDLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

46.78% of the earnings are spent on dividend by DLB. This is a bit on the high side, but may be sustainable.
DLB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP46.78%
EPS Next 2Y5.99%
EPS Next 3Y6.93%
DLB Yearly Income VS Free CF VS DividendDLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
DLB Dividend Payout.DLB Dividend Payout, showing the Payout Ratio.DLB Dividend Payout.PayoutRetained Earnings

DOLBY LABORATORIES INC-CL A

NYSE:DLB (11/3/2025, 12:54:55 PM)

65.875

-0.44 (-0.67%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-18 2025-11-18/amc
Inst Owners98.07%
Inst Owner Change0.21%
Ins Owners1.08%
Ins Owner Change-1.01%
Market Cap6.31B
Revenue(TTM)1.35B
Net Income(TTM)264.26M
Analysts78
Price Target97.67 (48.27%)
Short Float %3.61%
Short Ratio4.42
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend1.2
Dividend Growth(5Y)9.47%
DP46.78%
Div Incr Years10
Div Non Decr Years10
Ex-Date08-12 2025-08-12 (0.33)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.5%
Min EPS beat(2)4.74%
Max EPS beat(2)8.26%
EPS beat(4)4
Avg EPS beat(4)8.82%
Min EPS beat(4)4.74%
Max EPS beat(4)15.12%
EPS beat(8)8
Avg EPS beat(8)12.28%
EPS beat(12)10
Avg EPS beat(12)12.86%
EPS beat(16)13
Avg EPS beat(16)11.07%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)2.35%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)2.35%
Revenue beat(8)3
Avg Revenue beat(8)-0.12%
Revenue beat(12)5
Avg Revenue beat(12)0.14%
Revenue beat(16)5
Avg Revenue beat(16)-0.69%
PT rev (1m)0%
PT rev (3m)-1.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 16.19
Fwd PE 15.43
P/S 4.69
P/FCF 14.41
P/OCF 13.56
P/B 2.42
P/tB 3.79
EV/EBITDA 15.03
EPS(TTM)4.07
EY6.18%
EPS(NY)4.27
Fwd EY6.48%
FCF(TTM)4.57
FCFY6.94%
OCF(TTM)4.86
OCFY7.37%
SpS14.05
BVpS27.18
TBVpS17.4
PEG (NY)3.08
PEG (5Y)1.75
Graham Number49.89
Profitability
Industry RankSector Rank
ROA 8.27%
ROE 10.15%
ROCE 10.3%
ROIC 8.51%
ROICexc 11.34%
ROICexgc 20.41%
OM 21.47%
PM (TTM) 19.62%
GM 88.52%
FCFM 32.52%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
ROICexc(3y)11.36%
ROICexc(5y)12.88%
ROICexgc(3y)17.78%
ROICexgc(5y)19.47%
ROCE(3y)9.71%
ROCE(5y)9.93%
ROICexgc growth 3Y-12.75%
ROICexgc growth 5Y-4.71%
ROICexc growth 3Y-18.76%
ROICexc growth 5Y-8.2%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 31.52%
Cap/Sales 2.04%
Interest Coverage 250
Cash Conversion 123.68%
Profit Quality 165.77%
Current Ratio 3.44
Quick Ratio 3.36
Altman-Z 8.67
F-Score6
WACC11.05%
ROIC/WACC0.77
Cap/Depr(3y)47.88%
Cap/Depr(5y)55.27%
Cap/Sales(3y)3.14%
Cap/Sales(5y)3.93%
Profit Quality(3y)140.69%
Profit Quality(5y)133.53%
High Growth Momentum
Growth
EPS 1Y (TTM)11.81%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%9.86%
EPS Next Y5.25%
EPS Next 2Y5.99%
EPS Next 3Y6.93%
EPS Next 5YN/A
Revenue 1Y (TTM)6.94%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%9.25%
Revenue Next Year5.43%
Revenue Next 2Y4.92%
Revenue Next 3Y4.78%
Revenue Next 5YN/A
EBIT growth 1Y17.22%
EBIT growth 3Y-8.08%
EBIT growth 5Y-2.06%
EBIT Next Year26.84%
EBIT Next 3Y13.02%
EBIT Next 5YN/A
FCF growth 1Y45.82%
FCF growth 3Y-8.91%
FCF growth 5Y6.77%
OCF growth 1Y39.63%
OCF growth 3Y-9.93%
OCF growth 5Y-0.03%

DOLBY LABORATORIES INC-CL A / DLB FAQ

What is the fundamental rating for DLB stock?

ChartMill assigns a fundamental rating of 7 / 10 to DLB.


Can you provide the valuation status for DOLBY LABORATORIES INC-CL A?

ChartMill assigns a valuation rating of 6 / 10 to DOLBY LABORATORIES INC-CL A (DLB). This can be considered as Fairly Valued.


What is the profitability of DLB stock?

DOLBY LABORATORIES INC-CL A (DLB) has a profitability rating of 8 / 10.


What is the valuation of DOLBY LABORATORIES INC-CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DOLBY LABORATORIES INC-CL A (DLB) is 16.19 and the Price/Book (PB) ratio is 2.42.


Is the dividend of DOLBY LABORATORIES INC-CL A sustainable?

The dividend rating of DOLBY LABORATORIES INC-CL A (DLB) is 6 / 10 and the dividend payout ratio is 46.78%.